Number of Patient Visits to Primary Care and Specialist Physicians for Diagnoses With a Specialty Care Focus, by Overall Morbidity Burden
Overall Morbidity Burden | |||||||
---|---|---|---|---|---|---|---|
Lowest | Intermediate | Highest | |||||
Diagnosis | Prevalence per 1,000 | Visits to Primary Care | Visits to Specialists | Visits to Primary Care | Visits to Specialists | Visits to Primary Care | Visits to Specialists |
Note: A specialist focus implies the diagnosis is made more often for patients in specialty care than in primary care. Differences are significant at the .005 level (unless indicated by ns) using paired t tests with Hochberg multiple test family-wise error rate adjustment. Not all 87 diagnoses shown. | |||||||
Cataract, aphakia | 187 | 0.03 | 1.31 | 0.04 | 1.40 | 0.04 | 1.47 |
Ischemic heart disease | 152 | 0.90 | 1.17 | 1.01 | 1.35 | 1.08 | 1.60 |
Benign and unspecified neoplasm | 108 | 0.23 | 1.16 | 0.22 | 1.28 | 0.24 | 1.43 |
Skin keratoses | 108 | 0.14 | 1.31 | 0.13 | 1.41 | 0.12 | 1.52 |
Cardiac arrhythmia | 102 | 1.29 | 1.49 | 1.35 | 1.65 | 1.31 | 1.78 |
Glaucoma | 87 | 0.01 | 2.28 | 0.01 | 2.29 | 0.01 | 2.29 |
Low-impact malignant neoplasms | 82 | 0.38 | 2.79 | 0.50 | 3.31 | 0.62 | 4.03 |
Retinal disorders (excluding diabetic retinopathy) | 65 | 0.01 | 1.56 | 0.02 | 1.68 | 0.02 | 1.75 |
Cerebrovascular disease | 54 | 0.80 | 0.85 | 0.81 | 0.95 | 0.85 | 1.05 |
Urinary symptoms | 53 | 0.50 | 0.94 | 0.44 | 1.15 | 0.41 | 1.34 |
Prostatic hypertrophy | 52 | 0.41 | 0.97 | 0.35 | 1.15 | 0.28 | 1.34 |
Cardiovascular signs and symptoms | 51 | 0.59 | 0.62 | 0.58 | 0.71 | 0.56 | 0.80 |
Dermatitis and eczema | 49 | 0.51 | 0.88 | 0.43 | 1.02 | 0.38 | 1.17 |
Bursitis, synovitis, tenosynovitis | 48 | 0.67 | 0.82 | 0.59 | 1.04 | 0.55 | 1.34 |
Malignant neoplasms of the skin | 48 | 0.13 | 1.75 | 0.12 | 1.86 | 0.11 | 1.96 |
Surgical aftercare | 48 | 0.16 | 1.44 | 0.23 | 1.61 | 0.25 | 1.71 |
Cardiac valve disorders | 41 | 0.42 | 1.06 | 0.41 | 1.08 | 0.39 | 1.17 |
Allergic rhinitis | 37 | 1.12 | 1.93 | 1.20 | 2.27 | 1.14 | 2.69 |
Gastrointestinal signs and symptoms | 34 | 0.59 | 0.61 | 0.52 | 0.78 | 0.49 | 0.89 |
Peripheral neuropathy, neuritis | 29 | 0.64 | 1.04 | 0.57 | 1.24 | 0.53 | 1.40 |
Conjunctivitis, keratitis | 26 | 0.27 | 1.01 | 0.21 | 1.19 | 0.18 | 1.33 |
Disorders of the eyelid and lacrimal duct | 26 | 0.02 | 1.26 | 0.02 | 1.38 | 0.02 | 1.50 |
Fractures (excluding digits) | 26 | 0.45 | 1.62 | 0.45 | 1.60 | 0.48 | 1.51 |
Autoimmune and connective tissue disease | 24 | 1.12 | 1.93 | 1.30 | 2.16 | 1.34 | 2.34 |
Deafness, hearing loss | 24 | 0.17 | 0.98 | 0.14 | 1.07 | 0.09 | 1.16 |
Menopausal symptoms | 22 | 0.45 | 0.76 | 0.39 | 0.83 | 0.39 | 0.90 |
Peripheral vascular disease | 22 | 0.62 | 0.88 | 0.61 | 1.04 | 0.55 | 1.27 |
Vaginitis, vulvitis, cervicitis | 21 | 0.41 | 0.70 | 0.35 | 0.80 | 0.33 | 0.91 |
Other skin disorders | 19 | 0.49 | 0.68 | 0.44 | 0.74 | 0.37 | 0.84 |
Ophthalmic signs and symptoms | 16 | 0.06 | 1.04 | 0.08 | 1.06 | 0.10 | 1.09 |
High-impact malignant neoplasms | 16 | 0.62 | 3.51 | 0.93 | 4.36 | 0.98 | 4.89 |
Refractive errors | 15 | 0.00 | 1.02 | 0.00 | 1.04 | 0.00 | 1.05 |
Uterovaginal prolapse | 15 | 0.23 | 1.51 | 0.18 | 1.69 | 0.16 | 1.84 |
Infections of eyelid | 14 | 0.08 | 1.16 | 0.07 | 1.23 | 0.05 | 1.29 |
Sebaceous cyst | 14 | 0.44 | 0.87 | 0.34 | 0.96 | 0.26 | 1.04 |
Joint disorders, trauma related | 13 | 0.35 | 1.22 | 0.34 | 1.41 | 0.33 | 1.48 |